TrianglePUBLICATIONS · 38822537
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2024 Aug
- First author
- Barr EK
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Barr EK
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Twist CJ
- type
- Author
- name
- Tenney SC
- type
- Author
- name
- Schmidt ML
- type
- Author
- name
- London WB
- type
- Author
- name
- Gastier-Foster J
- type
- Author
- name
- Adkins ES
- type
- Author
- name
- Mattei P
- type
- Author
- name
- Handler MH
- type
- Author
- name
- Matthay KK
- type
- Author
- name
- Park JR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Barr EK
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Twist CJ
- type
- Author
- name
- Tenney SC
- type
- Author
- name
- Schmidt ML
- type
- Author
- name
- London WB
- type
- Author
- name
- Gastier-Foster J
- type
- Author
- name
- Adkins ES
- type
- Author
- name
- Mattei P
- type
- Author
- name
- Handler MH
- type
- Author
- name
- Matthay KK
- type
- Author
- name
- Park JR
- type
- Author
- bibliography ids
- nci-bib-af308d3825fee45d2900517d
- book metadata
- content sha256
- 8ec0345fe26bbc2acce095436ba3a0ad5adf136ecadbc9a48ef3e850231cc074
- document type
- citation
- dois
- 10.1002/pbc.31089
- electronic publication date
- display
- 2024 May 31
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38822537
- immutable id
- pubmed:38822537@8ec0345fe26bbc2acce095436ba3a0ad5adf136ecadbc9a48ef3e850231cc074
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 8
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- e31089
- volume
- 71
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38822537
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- d17cd0137104ef30b38fff7657e8704b9fb3e791dfda20182133059e61e1065c
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 Aug
- precision
- month
- year
- 2024
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Preserved source evidence · Not medical advice